RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN’S ONCOHEMATOLOGICAL DIVISION

The article provides an analysis of using medications in children’s oncohematological department in Tomsk in 2008. Over that period 52 children aged from 6 months to 18 years were treated (with an acute lymphatic leukaemia, lymphogranulomatosis, non Hodgkin lymphom, acute and chronic myeloblastic le...

Full description

Saved in:
Bibliographic Details
Main Authors: Z.A. Maevskaya, R.N. Luchinina, I.E. Gerbek, Yu.P. Chasovskikh, I.Yu. Smirnova, О.М. Fal'kovich
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2010-05-01
Series:Педиатрическая фармакология
Online Access:https://www.pedpharma.ru/jour/article/view/1137
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The article provides an analysis of using medications in children’s oncohematological department in Tomsk in 2008. Over that period 52 children aged from 6 months to 18 years were treated (with an acute lymphatic leukaemia, lymphogranulomatosis, non Hodgkin lymphom, acute and chronic myeloblastic leukemia, etc.). According to АВС/VEN analysis, 79,9% of funds was spent on acquisition of 11 group A medications, 15,1% — on group B medications, 5% — on group C medications. Vital medications (V) accounted for 79,4%, essential medications (Е) — 14,7%, non-essential medications (N) — 5,9%. The authors examined the toxicity of vincristine depending on manufacturers. Key words: children, malignant blood diseases, ABC/VEN analysis, vincristine, neurotoxicity. (Pediatric Pharmacology. – 2010; 7(3):14-16)
ISSN:1727-5776
2500-3089